RA 5921 RA 10918

An act regulating the practice of pharmacy An Act Regulating and Modernizing the
and settings standards of pharmaceutical Practice of Pharmacy in the Philippines,
education in the Philippines and for other Repealing for the Purpose Republic Act
purposes. Numbered Five Thousand Nine Hundred
Twenty-One (R.A. No. 5921), Otherwise
Known as the Pharmacy Law

------ Statement of Policy.

Objectives Objectives
- This act provides for and shall govern — This Act provides for and shall govern the:
(a) the standardization and regulation of (all from RA 5921 is stated with the following
pharmaceutical education; additional)
(b) the Administration of licensure (d) Development and enhancement of
examination, registration, and licensing of professional competence of pharmacists
pharmacists; through continuing professional development,
(c) the supervision, control, and regulation of research, and other related activities;
the practice of pharmacy in the Philippines. (e) Integration of the pharmacy profession

Definition of practice of pharmacy. Scope of the Practice of Pharmacy.

- A person shall be deemed to be practicing — A person is deemed to be practicing
pharmacy within the meaning of this Article, pharmacy,
who shall, for a fee, salary, percentage or within the meaning of this Act, when with or
other reward paid or given directly to himself without a fee, salary, percentage or other
or indirectly through another, rewards, paid or given directly or indirectly,
shall:
A. prepare or manufacture, analyze, assay, (all from RA 5921 is stated with the following
preserve, store, distribute or sell any additional)
medicine, drug chemicals, cosmetics,
pharmaceuticals, devices or contrivances (g) Administration of adult vaccines as
used in pursuance thereof; approved by the Food and Drug
Administration (FDA):
B. render pharmaceutical service in any office Provided, that they shall undergo the training
or drug and cosmetic establishment where on the safe administration of adult vaccines
scientific, technological or professional and management of adverse event following
knowledge of pharmacy is applied; or engage immunization (AEFI) for pharmacists and hold
in teaching scientific, technological or a certificate of training issued by an institution
professional pharmacy subject in a college of duly accredited by the Professional
Pharmacy; Regulation Commission (PRC); Provided,
Further, That the safe administration of
vaccines be part of the higher education
C. conduct or undertake scientific curriculum for pharmacists; or (h) Conduct or
pharmaceutical undertake scientific research in all aspects
research for biological and bacteriological involving pharmaceutical products and health
testing care; or
and examinations. (i) Provide other services where
pharmaceutical knowledge is required.
Activities under paragraphs (a), (b), (c), (d)
and (i) are exclusive to licensed pharmacists.
However, nothing herein shall be construed
as requiring other persons carrying out only
the activities under paragraphs (e), (f), (g)
and (h) to be licensed pharmacists, subject to
any qualification that is imposed by other
laws with respect to such particular activity.

Section 4. Functions. The functions of the Section 8. Powers, Functions, and

Council of Pharmaceutical Education shall be: Responsibilities of the Board. - The Board shall
exercise the following powers, functions, and
(a) To promulgate rules and regulations relative responsibilities:
to Pharmaceutical Education in the Philippines;
(a) Administer and implement the provisions of
(b) To submit such rules and regulations, which this Act;
shall have a binding effect, for implementation
to the proper agencies such as Department of (b) Promulgate rules and regulations,
Education, the Board of Pharmacy, the bona administrative orders, and issuances necessary
fide national pharmaceutical organizations in to carry out the provisions of this Act;
the Philippines and others;
(c) Prepare licensure examination questions,
(c) To recognize and accredit colleges of score, and rate the examinations and submit
pharmacy in the different private colleges and the results thereof to the PRC. The Board shall
universities; and prepare, adopt, issue, or amend the syllabi or
tables of specifications of the subjects in the
(d) To approve the accreditation of community licensure examination, in consultation with the
or prescription pharmacies, pharmaceutical academe and the Commission on Higher
manufacturing laboratories and hospital Education (CHED);
pharmacies for purposes of pharmacy
internship. (d) Recommend the issuance, suspension,
revocation, or reinstatement of the COR, PIC or
Section 11. Powers and duties of the Board. Special/Temporary Permits (STP) for the
The Board of Pharmacy, conformably with the practice of pharmacy;
provisions of this Act is vested with authority:
(e) Administer oaths in accordance with the
(a) To examine applicants for the practice of provisions of this Act;
pharmacy;
(f) Regulate and monitor the practice of
(b) To issue certificates of registration or pharmacy in the Philippines, including the
pharmacists. practice of subprofessional services such as
pharmacy technicians, pharmacy assistants,
(c) To reprimand any pharmacist or to suspend aides, and other medicine handlers, as
or revoke his certificate of registration on the described in this Act; adopt measures that may
grounds as provided for in Section thirteen be deemed proper for the enhancement of the
hereof, after a formal administrative profession and the maintenance of high
investigation has been conducted by it. professional, academic, ethical, and technical
standards; and conduct ocular inspection of
(d) To promulgate from time to time the
necessary rules and regulations for the effective pharmaceutical establishments and higher
enforcement of this Act, subject to the approval education institutions (HEIs), in coordination
of the President upon advice of the with concerned government agencies;
Commissioner of Civil Service;
(g) Promulgate and prescribe the Pharmacists’
(e) To study the conditions affecting the practice Code of Ethics, Code of Technical Standards
of pharmacy in the Philippines; and Guidelines for the Professional Practice of
the Pharmacy Profession, in coordination with
(f) To check the employment of qualified the APO;
personnel in drug stores, hospital pharmacies,
drug or pharmaceutical laboratories, cosmetic (h) Represent the pharmacy profession in all
laboratories and similar establishments for fora involving concerns and issues related to
which the Board may designate inspectors from pharmaceutical products and the practice of
the Board of Pharmacy; and pharmacy;

(g) To encourage the development of botanical (i) Investigate cases arising from violations of
gardens and their inspection particularly the this Act, the rules and regulations promulgated
propagation of Philippine medicinal plants with pursuant thereto, the Pharmacists’ Code of
the cooperation of the Department of Agriculture Ethics, Code of Technical Standards and
and Natural Resources. Guidelines for the Professional Practice of the
Pharmacy Profession, and other Board
issuances; issue summons, subpoena ad
testificandum and subpoena duces tecum to
secure the attendance of witnesses or
production of documents, or both, and other
evidence necessary for such investigation or
hearing; and render decision thereon which
shall, unless appealed to the PRC, become
final and executory after fifteen (15) days from
receipt of notice of judgment or decision;

(j) Delegate the he aring or investigation of

administrative cases filed before the Board,
except where the issue or question involves the
practice of the profession, in which case, the
hearing shall be presided over by at least one
(1) member of the Board, to be assisted by a
Legal or Hearing Officer of the PRC;

(k) Conduct, through the Legal Officers of the

PRC, summary proceedings on minor violations
of this Act, the General Instruction to the
Examinees, including the implementing rules
and regulations issued by the Board, and to
render summary judgment thereon which shall,
unless appealed to the PRC, become final and
executory after fifteen (15) days from receipt of
notice of judgment or decision;

(l) Issue and promulgate guidelines on CPD, in

coordination with the APO;

(m) Recommend the accreditation of the

 standardized training programs for and
certifications of medical representatives or
professional service representatives, pharmacy
technicians, pharmacy assistants, pharmacy
aides and other medicine handlers covered in
Section 39, Article IV of this Act. The Board
shall promulgate the criteria and guidelines in
the accreditation of training programs and
certifications as described above, in
coordination with the APO and with other
concerned government agencies;

(n) Accredit Specialty Boards of Pharmacy

based on the criteria that it shall establish and
prescribe; and

(o) Perform and discharge such other functions

and responsibilities, as may be deemed
implied, incidental, and necessary, to preserve
the integrity of the pharmacy licensure
examination and to enhance and upgrade the
practice of the pharmacy profession in the
country.

Section 7. Qualification of Board members. To Section 7. Qualifications of the Chairperson

be appointed a member of the Board of and Members of the Board. - The Chairperson
Pharmacy, a person shall be: and members of the Board, at the time of
nomination, must:
(a) A natural born citizen of the Philippines;
(a) Be a citizen of the Philippines and a resident
(b) A duly registered pharmacist and has been for at least five (5) years;
in the practice of pharmacy for at least ten
years; (b) Be a duly registered and licensed
pharmacist in the Philippines, preferably a
(c) Of good moral character and of recognized holder of a masteral degree in Pharmacy, or its
standing in the pharmaceutical profession; equivalent;

(d) At the time of appointment, not a member of (c) Have been in the active practice of
the faculty of any school, college or university pharmacy for the past ten (10) years;
offering courses in pharmacy; nor have any
direct or indirect pecuniary interests in such (d) Have not been convicted of a crime
school or college of pharmacy; and involving moral turpitude;

(e) A member of good standing of any bona fide (e) Be a member in good standing of the APO
national pharmaceutical association of the for at least five (5) years, but not an officer or
Philippines. trustee thereof; and

(f) At the time of appointment, must neither be a

member of the faculty nor an administrative
officer of any school, college or university
 offering degree programs in pharmacy nor has
any direct or indirect pecuniary interest or
connection in any review center or similar
institution.

Section 42. Definition of terms. For purposes of Section 5. Definition of Terms. - As used in this
this Act, the term Act:

(a) "Pharmacy" or "Drug Store" means a place (a) Accredited professional organization (APO)
or establishment where drugs, chemical refers to the duly integrated and accredited
products, active principles of drugs, professional organization of registered and
pharmaceuticals, proprietary medicines or licensed pharmacists, of which there shall be
pharmaceutical specialties, devices, and only one (1), as prescribed under Section 41,
poisons are sold at retail and where medical, Article V of this Act;
dental and veterinary prescriptions are
compounded and dispensed. (b) Adult vaccines refer to cervical cancer, flu
(influenza), pneumococcal, other pre-exposure
(b) "Drug or Pharmaceutical Laboratory" or prophylactic vaccines to be administered to
``Pharmaceutical Manufacturing Laboratory" patients aged eighteen (18) years and above,
means an establishment where and such other vaccines as may be defined by
pharmaceuticals, proprietary medicines or the Department of Health (DOH) in an
pharmaceutical specialties are prepared, administrative issuance;
compounded, standardized and distributed or
sold. (c) Adulterated/Deteriorated pharmaceutical
products refer to pharmaceutical products unfit
(c) "Wholesaler" means and includes every for human consumption, following the standards
person who acts as a jobber, merchant, broker of quality or purity of which, are as those stated
or agent, who sells or distributes for resale in the United States Pharmacopeia/National
pharmaceuticals, proprietary medicines or Formulary and Philippine Pharmacopeia in its
pharmaceutical specialties. latest edition or any standard reference for
drugs and medicines which are given official
(d) "Person" means and includes an individual, recognition as well as those provided for in
partnership, corporation or association. Republic Act No. 3720, otherwise known as the
"Food, Drug, and Cosmetic Act", as amended,
(e) "Drug" means (1) articles recognized in the and Republic Act No. 9711, known as the "Food
official United States Pharmacopoeia, official and Drug Administration Act of 2009";
Homeopathic Pharmacopoeia of the United
States or official National Formulary, or any of (d) Biopharmaceuticals refer to pharmaceutical
their supplements; (2) articles intended for use products that are used for therapeutic or for in
in the diagnosis, cure, mitigation, treatment, or vivo diagnostic purposes, such as vaccines,
prevention of disease in man or animals; (3) sera, and drugs derived from life forms using
articles (other than food) intended to effect the biotechnology. These include proteins, nucleic
structure or any function of the body of man or acids, or living microorganisms where the
animals; and (4) articles intended for use as a virulence is reduced and are used for
component of any articles specified in clauses therapeutic or for in vivo diagnostic purposes;
(1), (2), or (3), but not include devices or their
components, parts or accessories. (e) Brand name refers to the proprietary name
given by the manufacturer to distinguish its
(f) "Pharmaceuticals", "Proprietary Medicines"
or "Pharmaceutical Specialties" means any product from those of competitors;
drug, preparation or mixture of drugs marked
under a trade name and intended for the cure, (f) Cipher, Code, or Secret Key refers to a
mitigation or prevention of disease in man or method of secret writing or use of characteristic
animals. style or symbol by substituting other letter/s or
character/s for the letter/s intended, for the
(g) "Device" means instruments, apparatus or purpose of misleading the consumer;
contrivances including their components, parts
and accessories, intended (1) for use in the (g) Compounding refers to the sum of
diagnosis, cure, mitigation, treatment or processes performed by a pharmacist in drug
prevention of disease in man or animals; or(2) preparation including the calculations, mixing,
to affect the structure or any function of the assembling, packaging, or labeling of a drug: (i)
body of man or animals. as the result of a prescription or drug order by a
physician, dentist, or veterinarian; or (ii) for the
(h) "Biologic Products" are viruses, sera, toxins purpose of, or in relation to, research, teaching,
and analogous products used for the prevention or chemical analysis;
or cure of human diseases.
(h) Continuing professional development (CPD)
(i) "Poison" is any drug, active principle, or refers to the inculcation of advanced
preparation of the same, capable of destroying knowledge, skills, and ethical values in a
life or seriously endangering health when post-licensure specialized or in an inter- or
applied externally to the body or introduced multidisciplinary field of study for assimilation
internally in moderate doses. into professional practice, self-directed
research, and/or lifelong learning;
(j) "Cipher" means a method of secret writing
that substitutes other letters or characters for (i) Cosmetics refer to a substance or
the letter intended or transposes the letter after preparation intended to be placed in contact
arranging them in blocks or squares. with the various external parts of the human
body or with the teeth and the mucous
(k) "Code" means a system of words or other membranes of the oral cavity, with a view
symbols arbitrarily used to represent words. exclusively or mainly to cleaning them,
perfuming them, changing their appearance
(l) "Secret Keys" means a characteristic style or and/or correcting body odor, and/or protecting
symbols kept from the knowledge of others or the body or keeping them in good condition, as
disclosed confidentially to but one of few. defined under Republic Act No. 9711;

(j) Counterfeit pharmaceutical products refer to

pharmaceutical products which do not contain
the amounts as claimed; with wrong
ingredients; without active ingredients; or with
insufficient quantity of active ingredients, which
result in the reduction of the products’ safety,
efficacy, quality, strength, or purity. These also
refer to products that are deliberately and
fraudulently mislabeled with respect to identity
and/or source or with fake packaging, and can
apply to both branded and generic products,
including the following:

(1) The pharmaceutical product itself or the

container or labeling thereof or any part of such
product, container, or labeling, bearing without
authorization; the trademark, trade name, or
other identification marks or imprints or any
likeness to that which is owned or registered in
the Intellectual Property Office (IPO) in the
name of another natural or juridical person;

(2) A pharmaceutical product refilled in

containers bearing legitimate labels or marks,
without authority; and

(3) A pharmaceutical product which contains no

amount of or a different active ingredient; or
less than eighty percent (80%) of the active
ingredient it purports to possess, as
distinguished from an adulterated drug
including reduction or loss of efficacy due to
expiration;

(k) Dangerous drugs refer to those listed in the:

(1) Schedules annexed to the 1961 Single
Convention on Narcotic Drugs, as amended by
the 1972 Protocol; (2) Schedules annexed to
the 1971 Single Convention on Psychotropic
Substances; and (3) Annex of Republic Act No.
9165, otherwise known as the "Comprehensive
Dangerous Drugs Act of 2002", and its
amendments;

(l) Dispensing refers to the sum of processes

performed by a pharmacist from reading,
validating, and interpreting prescriptions;
preparing; packaging; labeling; record keeping;
dose calculations; and counseling or giving
information, in relation to the sale or transfer of
pharmaceutical products, with or without a
prescription or medication order;

(m) Drugs refer to pharmaceutical products that

pertain to chemical compounds or biological
substances, other than food, intended for use in
the treatment, prevention, or diagnosis of
disease in humans or animals, including the
following:

(1) Any article recognized in the official United

States Pharmacopeia/National Formulary,
Homeopathic Pharmacopeia of the United
States of America, Philippine Pharmacopeia,
Philippine National Drug Formulary, British
Pharmacopoeia, European Pharmacopoeia,
Japanese Pharmacopoeia, and any official
compendium or any supplement to them;

(2) Any article intended for use in diagnosis,

cure, mitigation, treatment, or prevention of
disease of man or animals;

(3) Any article, other than food, intended to

affect the structure or any function of the human
body or animals;

(4) Any article intended for use, as a

component of articles, specified in clauses (1),
(2) and (3), not including devices or their
components, parts and accessories; and

(5) Herbal or traditional drugs as defined in

Republic Act No. 9502;

(n) Emergency cases refer to life-threatening

situations where a patient needs immediate
medical attention and treatment, including the
occurrence of epidemic or natural calamities;

(o) Expiration date refers to the end date when

the manufacturer can guarantee that a product
possesses its claimed potency, efficacy, quality,
and safety; after which its sale or distribution is
prohibited;

(p) Filling refers to the act of dispensing or

providing medicines in accordance with a
prescription or medication order;

(q) Food/Dietary supplements refer to

processed food products intended to
supplement the diet that bears or contains one
(1) or more of the following dietary ingredients:
vitamins, minerals, herbs, or other botanicals,
amino acids, and dietary substances to
increase the total daily intake in amounts
conforming to the latest
Philippine-recommended energy and nutrient
intakes or internationally agreed minimum daily
requirements. It usually is in the form of
capsules, tablets, liquids, gels, powders, or pills
and not represented for use as a conventional
food or as the sole item of a meal or diet or
replacement of drugs and medicines, as
defined under Republic Act No. 9711;

(r) Generic name refers to the scientifically and

internationally recognized name of the active
ingredients, as approved by the FDA pursuant
to Republic Act No. 6675, otherwise known as
the "Generics Act of 1988";
(s) Health supplement refers to any product that
is used to maintain, enhance and improve the
healthy function of the human body and
contains one (1) or more or a combination of
the following: (1) herbal fatty adds, enzymes,
probiotics, and other bioactive substances; and
(2) substances derived from natural sources,
induding animal, plant, mineral, and botanical
materials in the form of extracts, isolates,
concentrates, metabolites, synthetic sources of
substances mentioned in (1) and (2). It is
presented in dosage forms or in small unit
doses such as capsules, tablets, powder,
liquids and it shall not include any sterile
preparations (i.e. injectibles, eyedrops);

(t) Household remedies refer to any preparation

containing pharmaceutical substances of
common or ordinary use to relieve common
physical ailments and which may be dispensed
without a medical prescription in original
packages, bottles or containers, of which the
nomenclature has been duly approved by the
FDA;

(u) Institutional pharmacies refer to pharmacies

of institutions, organizations, and/or
corporations that provide a range of
pharmaceutical services, given exclusively to
the employees and/or their qualified
dependents;

(v) Internship program refers to a supervised

practical experience that is required to be
completed for licensure as a registered
pharmacist;

(w) Label refers to a display of written, printed,

or graphic matter on the immediate container of
any article;

(x) Labeling materials refer to all labels and

other written, printed, or graphic matter: (1)
upon any item or any of its containers or
wrappers; or (2) accompanying any such item;

(y) Medical device refers to any instrument,

apparatus, implement, machine, appliance,
implant, in vitro reagent or calibrator, software,
material or other similar or related article
intended by the manufacturer to be used alone,
or in combination, for human beings, for one (1)
or more of the specific purposes of: diagnosis,
prevention, monitoring, treatment, or alleviation
of disease; diagnosis, monitoring, treatment, or
alleviation of or compensation for an injury;
investigation, replacement, modification or
support of the anatomy of a physiological
process; supporting or sustaining life;
preventing infection; control of conception;
disinfection of medical devices; and providing
information for medical or diagnostic purposes
by means of in vitro examination of specimens
derived from the human body. This device does
not achieve its primary intended action in or on
the human body by pharmacological,
immunological, or metabolic means, but which
may be assisted in its intended function by such
means, as defined under Republic Act No.
9711;

(z) Medical mission refers to an activity

conducted on normal circumstances of an
individual or a group of health care practitioners
to provide health services outside the hospital,
clinic, and health care facility premises as
differentiated from humanitarian missions and
relief operations which is conducted during
emergency situations such as calamity, war, or
natural and man-made disasters;

(aa) Medicines refer to drugs in their

appropriate dosage forms, with assured quality,
safety and efficacy for humans or animals, or
both;

(bb) Medical representative or professional

service representative refers to one who
represents any duly authorized manufacturer,
distributor, trader, and wholesaler of
pharmaceutical products and whose primary
duty is to promote their products to duly
licensed health professionals;

(cc) Nontraditional outlets refer to entities

licensed by appropriate government agencies
to dispense over-the-counter medicines based
on an approved list;

(dd) Online pharmacy services refer to

pharmaceutical services of a duly licensed
pharmaceutical outlet done over the internet;

(ee) Over-the-counter (OTC) medicines refer to

medicines used for symptomatic relief of minor
ailments and which may be dispensed without a
prescription;

(ff) Pharmaceutical establishments refer to

entities licensed by appropriate government
agencies, and which are involved in the
manufacture, importation, exportation,
repacking, and distribution of pharmaceutical
products to pharmaceutical outlets;

(gg) Pharmaceutical manufacturers refer to

establishments engaged in any or all operations
involved in the production of pharmaceutical
products including the preparation, processing,
compounding, formulating, filling, packaging,
repackaging, altering, ornamenting, finishing
and labeling, preparatory to their storage, sale,
or distribution, except the compounding and
filling of prescriptions in pharmaceutical outlets;

(hh) Pharmaceutical marketing refers to any

activity undertaken, organized, or sponsored by
a pharmaceutical establishment or outlet which
is directed at promoting its product;

(ii) Pharmaceutical outlets refer to entities

licensed by appropriate government agencies,
and which are involved in compounding and/or
dispensing and selling of pharmaceutical
products directly to patients or end-users;

(jj) Pharmaceutical products refer to drugs,

medicines, biologicals, pharmaceutical and
biopharmaceutical products/specialties,
veterinary products, veterinary biologies and
veterinary medicinal products;

(kk) Pharmacist refers to a health professional

who has been registered and issued a valid
Certificate of Registration (COR) and
Professional Identification Card (PIC) by the
PRC and the Professional Regulatory Board of
Pharmacy;

(ll) Pharmacist-only OTC medicines refer to

over-the-counter medicines classified by
appropriate government agencies to be
obtained only from a licensed pharmacist, with
mandatory pharmacist’s advice on their
selection and proper use;

(mm) Pharmacy aides refer to persons who

assist the pharmacists in the different aspects
of pharmacy operation based on established
standard operating procedures and processes,
with very minimal degree of independence or
decision making and without direct interaction
with patients:

(nn) Pharmacy assistants refer to persons who

assist the pharmacists in different aspects of
pharmacy operation based on established
standard operating procedures and processes,
with a minimum degree of independence or
decision making and may have supervised
interaction with patients;

(oo) Pharmacy technicians refer to persons who

assist in compounding and dispensing of
medicines in community, hospital, institutional
and industrial settings or engaged in other
activities under the supervision of the
pharmacist as described in Section 39, Article
IV of this Act;

(pp) Philippine Practice Standards for

Pharmacists refer to the established national
framework for quality standards and guidelines
of the practice of pharmacy that respond to the
needs of the people who require the
pharmacists’ services to provide optimal,
evidence-based care as formulated by the
integrated APO and approved by the
Professional Regulatory Board of Pharmacy;

(qq) Physician’s samples refer to medicines

given to health professionals for promotional
purposes only;

(rr) Prescription/Ethical medicines refer to

medicines which can only be dispensed by a
pharmacist to a patient, upon the presentation
of a valid prescription from a physician, dentist,
or veterinarian and for which a pharmacist’s
advice is necessary;

(ss) Refilling of a prescription refers to the act of

dispensing the remaining balance of medicines
ordered in the prescription;

(tt) Referral refers to the process wherein a

pharmacist provides consultative services and
conducts preliminary assessment of symptoms
and refers the patient to a physician or other
health care professional;

(uu) Referral registry refers to the record book

 maintained by pharmacists, listing the patients
referred to different health facilities for further
diagnosis;

(vv) Refresher program refers to a prescribed

study program in an accredited school of
pharmacy; and

(ww) Telepharmacy services refer to

pharmaceutical services of a duly licensed
pharmaceutical outlet done through the use of
telephone, teleconferencing, or facsimile.

------- Section 18. Report of Rating. - The Board shall

submit to the PRC the ratings obtained by each
candidate within three (3) working days after
the last day of the examination, unless
extended for just cause.Upon the release of the
results of the examination, the PRC shall send
by mail the rating obtained by each examinee at
the given address using the mailing envelope
submitted during the examination.

Section 19. Oath of Profession. - All successful

candidates in the licensure examination shall
take their oath of profession before any
member of the Board, officer of the PRC, or any
person authorized by law to administer oaths,
prior to entering the practice of the pharmacy
profession.

Section 20. Issuance of Certificate of

Registration and Professional Identification
Card. - A COR as a pharmacist shall be issued
to those who passed the licensure examination,
subject to compliance with the registration
requirements and payment of the prescribed
fees. The COR shall bear the registration
number, the date of its issuance, and the
signatures of the Chairperson of the PRC and
the members of the Board, stamped with the
official seals of the PRC and of the Board,
certifying that the person named therein is
entitled to the practice of the profession, with all
the privileges appurtenant thereto. This COR
shall remain in full force and effect until
suspended or revoked in accordance with this
Act.

A PIC bearing the registration number and

dates of its issuance and expiry, duly signed by
the Chairperson of the PRC, shall likewise be
issued to every registrant, upon payment of the
prescribed fees. The PIC shall be renewed
every three (3) years, upon presentation of the
Certificate of Good Standing (COGS) from the
APO and proof of completion of the CPD
requirements.

Section 21. Foreign Reciprocity. - Unless the

country or state of which the foreign pharmacist
is a subject or citizen, specifically permits
Filipino pharmacists to practice within its
territorial limits on the same basis as the
subjects or citizens of the said foreign country
or state under reciprocity and under
international agreements, no foreigner shall be
admitted to licensure examinations, given a
COR to practice as pharmacist nor be entitled
to any of the privileges under this Act.

Section 22. Practice Through

Special/Temporary Permit (STP). - The practice
of pharmacy in the Philippines shall be limited
to natural persons only and shall be governed
by the provisions of Republic Act No. 8981 and
other issuances pertinent thereto: Provided,
That any foreign citizen who has gained entry in
the Philippines to perform professional services
within the scope of the practice of pharmacy,
including the following: (a) being a consultant in
foreign-funded or assisted projects of the
government; (b) being engaged or employed by
a Filipino employer or establishment; (c)
providing free services in humanitarian
missions: and (d) being a visiting faculty
member in any field or specialty in pharmacy
shall, before assuming such duties, functions
and responsibilities, secure an STP from the
Board and the PRC, under the following
conditions:

(1) The person is an internationally renowned

pharmacist or expert in a field or specialty of
pharmacy;

(2) The person is engaged in the provision of a

professional service which is determined to be
necessary due to lack of Filipino specialist or
expert; and

(3) The person is required to work with a

Filipino counterpart, a natural person who is a
 registered and licensed pharmacist.

Section 5. Meetings and traveling expenses. Section 10. Compensation and Allowances of
The Council of Pharmaceutical Education shall the Board. - The Chairperson and members of
meet at least once a month for regular business the Board shall receive compensation and
and as often as the Council may decide. The allowances comparable to the compensation
Chairman and members of the Council of and allowances received by the members of the
Pharmaceutical Education shall not be entitled other existing professional regulatory boards
to any compensation except for traveling under the PRC, as provided for in the General
expenses in connection with their official duties Appropriations Act.
as herein provided.

Section 43. Final Provisions. To carry out the Article VIII

provisions of this Act, thereby authorized to be
appropriated, out of any funds in the National Final Provisions
Treasury not otherwise appropriated, the sum of
thirty thousand pesos within the fiscal year of Section 47. Enforcement. - It shall be the
the approval hereof. Thereafter, such funds as primary duty of the Board and the PRC to
are necessary for the maintenance and effectively enforce the provisions of this Act. All
operation of the Board of Pharmacy and of the duly constituted law enforcement agencies and
Council of Pharmaceutical Education shall be officers of the national, provincial, city or
included in the annual General Appropriations municipal government or of any political
Act. subdivision thereof shall ensure the effective
enforcement and implementation of the
provisions of this Act.

Section 48. Appropriations. - The Chairperson

of the PRC shall immediately include in its
programs the implementation of this Act, the
funding of which shall be charged against their
current years’ appropriations and thereafter, in
the annual General Appropriations Act. 1âwphi1

Section 49. Transitory Provisions. - The

incumbent Chairperson and members of the
Board shall, in an interim capacity, continue to
function as such until the Chairperson and
members of the new Board, created under this
Act, shall have been appointed and qualified.

Section 50. Implementing Rules and

Regulations. - Within one hundred twenty (120)
days after the approval of this Act, the Board,
subject to the approval by the PRC, and in
consultation with the APO, shall formulate and
issue the rules and regulations to implement the
provisions of this Act.

Section 51. Separability Clause. - If any clause,

provision, paragraph or part hereof shall be
declared unconstitutional or invalid, such
declaration shall not affect, invalidate, or impair
the other provisions otherwise valid and
effective.